GoldenGolden
Advanced Search
Baylor College of Medicine

Baylor College of Medicine

An academic health science center and offers education, research and patient care. It was founded in 1900 and is located in Houston, Texas.

Baylor College of Medicine (BCM) is a health sciences university that applies science and discoveries to further education, healthcare and community service locally and globally.It offers programs for various disciplines and has schools in the fields of medicine, biomedical sciences, health professions, and tropical medicine.

COVID-19

During the COVID-19 pandemic, the college partnered with the Gulf Coast Regional Blood Center to conduct a transfusion study in which blood plasma is taken from those recovered from the virus and injected into people currently battling it.

Timeline

Patents

People

Name
Role
LinkedIn

Dr. Paul Klotman

President

Further reading

Title
Author
Link
Type
Date

Baylor College of Medicine, Gulf Coast Regional Blood Center, other hospitals join focus on transfusion study

Hunter Marrow

Web

April 9, 2020

Texas doctors are using plasma from recovered COVID-19 patients to treat others. They're not yet sure if it will work.

Clare Proctor

Web

April 12, 2020

Documentaries, videos and podcasts

Title
Date
Link

Baylor College of Medicine Match Day 2020

March 20, 2020

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
Science X staff
May 27, 2021
phys.org
One hundred fifty years ago, Dmitri Mendeleev created the periodic table, a system for classifying atoms based on the properties of their nuclei. This week, a team of biologists studying the tree of life has unveiled a new classification system for cell nuclei and discovered a method for transmuting one type of cell nucleus into another.
Arlene Weintraub
May 17, 2021
FierceBiotech
Baylor researchers have discovered a pathway by which ER/HER2-positive breast tumors can transform into more aggressive, ER-negative-like subtypes--a discovery that could change the way breast cancer is tracked and treated, they believe. The key is the enzyme MAP kinase.
Leroy Leo
April 24, 2021
mint
In the first and second phase of the trial, the Hyderabad-based vaccine maker studied the safety and immunogenicity of the vaccine candidate in about 360 participants in the age group of 18 to 65 years
April 24, 2021
Moneycontrol
The Phase III clinical study, which is to be conducted in 15 sites across India, will evaluate the Immunogenicity and Safety of Biological E's SARS-CoV-2 COVID-19 vaccine for protection against COVID-19 disease in about 1,268 healthy subjects in the age range of 18 to 80 years. It is intended to be part of a larger global Phase III study.
Sohini Das
April 24, 2021
@bsindia
The phase III clinical study, to be conducted in 15 sites across India, will evaluate the immunogenicity and safety of Biological Es vaccine candidate in 1,268 healthy subjects
SHOW MORE

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.